You are here: Industry Insights > melanoma

News List

NICE recommends monotherapy for adjuvant treatment of stage 3 melanoma pharmatimes
December 17, 2021
The approval follows a successful period of monitoring and patient access through the Cancer Drugs Fund.
FDA Approves Merck’s KEYTRUDA® as Adjuvant Treatment for Patients with Stage IIB or IIC Melanoma AmericanPharmaceuticalReview
December 07, 2021
Merck announced that the FDA has approved KEYTRUDA, Merck’s anti-PD-1 therapy, for the adjuvant treatment of adult and pediatric (12 years and older) patients with stage IIB or IIC melanoma following complete resection.
Merck’s Keytruda obtains FDA approval as adjuvant therapy for melanoma patients Pharmaceutical-Business-Review
December 07, 2021
Merck’s anti-PD-1 therapy, Keytruda, has obtained approval from the US Food and Drug Administration (FDA) as an adjuvant therapy for stage IIB or IIC melanoma patients aged 12 years and above.
BioNTech Receives FDA Fast Track Designation for its FixVac Candidate BNT111 in Advanced Melanoma AmericanPharmaceuticalReview
November 22, 2021
BioNTech SE announced that the FDA granted Fast Track Designation for BNT111, an investigational cancer immunotherapy for the potential treatment of advanced melanoma.
Ascentage Pharma's MDM2-p53 Inhibitor Alrizomadlin (APG-115) Granted Fast Track Designation by the US FDA for the Treatment of Relapsed/Refractory Unresectable or Metastatic Melanoma prnasia
September 28, 2021
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that...
Spotting the Signs of Deadly Melanoma Skin Cancers drugs
August 23, 2021
Regular skin checks to look for signs of melanoma could save your life.
Antibiotics may help to treat melanoma worldpharmanews
July 23, 2021
Some antibiotics appear to be effective against a form of skin cancer known as melanoma. Researchers at KU Leuven, Belgium, examined the effect of these antibiotics on patient-derived tumours in mice.
U.S. Cancer Mortality Rates Down From 2014 to 2018 drugs
July 09, 2021
Cancer death rates in the United States continued to decline overall from 2014 to 2018, with declines accelerating for lung cancer and melanoma, according to a report published online July 8 in the Journal of the National Cancer Institute.
OncoSec Enters into a Collaboration Agreement with Merck for a Pivotal Global Phase 3 Study, KEYNOTE-C87, of TAVO Combined with KEYTRUDA for Late-Stage Metastatic Melanoma firstwordpharma
July 07, 2021
OncoSec Medical Incorporated (NASDAQ:ONCS) (the "Company" or "OncoSec") today announced it has entered into a Clinical Trial Collaboration and Supply Agreement with Merck to to evaluate the combination of OncoSec's DNA-plasmid interleukin-12
European Organisation for Research and Treatment of Cancer (EORTC) and Pierre Fabre Partner to Address Treatment Gap for Stage 2 Melanoma Patients prnasia
June 30, 2021
European Organisation for Research and Treatment of Cancer (EORTC) and Pierre Fabre announced a strategic partnership in support of patients with resected Stage 2 BRAF-mutant melanoma.

Previous page 1 2 3 4 5 6 7 Next page